Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab.

Knight, Tyler; Bond, T Christopher; Popelar, Breanna; Wang, Li; Niewoehner, John W; Anastassopoulos, Kathryn; Philbin, Michael

Knight, Tyler; Bond, T Christopher; Popelar, Breanna; Wang, Li; Niewoehner, John W; Anastassopoulos, Kathryn; Philbin, Michael.

Afiliación

Knight T; Covance Market Access Services Inc., Gaithersburg, MD.
Bond TC; Covance Market Access Services Inc., Gaithersburg, MD.
Popelar B; Xcenda, LLC, Palm Harbor, FL.
Wang L; STATinMED Research, Ann Arbor, MI.
Niewoehner JW; Mallinckrodt, LLC, Hazelwood, MO, USA.
Anastassopoulos K; Covance Market Access Services Inc., Gaithersburg, MD.
Philbin M; Mallinckrodt, LLC, Hazelwood, MO, USA.

Clinicoecon Outcomes Res ; 9: 271-279, 2017.

Article en En | MEDLINE | ID: mdl-28553129

Palabras clave

adrenocorticotropic hormone; costs; dermatomyositis; polymyositis; resource

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clinicoecon Outcomes Res Año: 2017 Tipo del documento: Article País de afiliación: Moldova

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google